Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Tried to tell u all those warrants and free options
View:
Post by Dumbeldorfwhite on Oct 22, 2024 12:10pm

Tried to tell u all those warrants and free options

Will make it very tough to climb.
Comment by Galaxym31 on Oct 22, 2024 12:13pm
Money in the bank nice try .
Comment by Galaxym31 on Oct 22, 2024 12:15pm
Such a cute dumpling .
Comment by riverrrow on Oct 22, 2024 12:55pm
I believe there are some warrants that expire mid November exercisable at 35 cents.  A lot of warrants have been extended to 2025 and beyond.  These warrants are a free investment to ride until TLT reaches 1 or 2 billion market cap.  Many warrant holders will likely hold their warrants until then.  GLTA.
Comment by 2b7f6fab on Oct 22, 2024 1:07pm
I don't see it that way.  I own a lot of warrants and won't exercise them till I can sell some shares at $1usd or more.  There's 34 million warrants currently oustanding and I suspect a lot of investors like me want to see a payday on my existing shares before exercising warrants.  Realize that when BTD is granted a lot more money than $34 million dollars will come ...more  
Comment by Dumbeldorfwhite on Oct 22, 2024 3:54pm
Doesn't matter how you or anyone else sees it, it's a fact. Whether it's at 1 dollar or not it's dilution and float throw in the 30 million or whatever in options and now the price is punished.
Comment by Galaxym31 on Oct 22, 2024 3:55pm
Yawn.
Comment by 2b7f6fab on Oct 22, 2024 5:34pm
Look Scooter, if all the warrants and options are exercised that brings in at least $13 million.  Enough to finish this trial and get another trial going without any further dilution.  It's known as rewarding your existing shareholder base.  Then the takeout with less than 300 million shares fully diluted.
Comment by CAinPlap on Oct 22, 2024 5:45pm
Dummy does seem desperate. lol  By his logic the stock market shouldn't exist because any dilution is bad. lololol
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250